Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.

Oncotarget

Fadejeva I, Olschewski H, Hrzenjak A.
PMID: 29383199
Oncotarget. 2017 Dec 05;8(70):115754-115773. doi: 10.18632/oncotarget.22975. eCollection 2017 Dec 29.

With more than 80% of all diagnosed lung cancer cases, non-small cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide. Exact diagnosis is mostly very late and advanced-stage NSCLCs are inoperable at admission. Tailored therapies with...

Cite
Fadejeva I, Olschewski H, Hrzenjak A. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas. Oncotarget. 2017;8(70):115754-115773doi: 10.18632/oncotarget.22975.
Fadejeva, I., Olschewski, H., & Hrzenjak, A. (2017). MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas. Oncotarget, 8(70), 115754-115773. https://doi.org/10.18632/oncotarget.22975
Fadejeva, Irina, et al. "MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas." Oncotarget vol. 8,70 (2017): 115754-115773. doi: https://doi.org/10.18632/oncotarget.22975
Fadejeva I, Olschewski H, Hrzenjak A. MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas. Oncotarget. 2017 Dec 05;8(70):115754-115773. doi: 10.18632/oncotarget.22975. eCollection 2017 Dec 29. PMID: 29383199; PMCID: PMC5777811.
Copy Download .nbib Format: NLM
Phospholipid dynamics in ex vivo lung cancer and normal lung explants.

Experimental & molecular medicine

Lesko J, Triebl A, Stacher-Priehse E, Fink-Neuböck N, Lindenmann J, Smolle-Jüttner FM, Köfeler HC, Hrzenjak A, Olschewski H, Leithner K.
PMID: 33408336
Exp Mol Med. 2021 Jan;53(1):81-90. doi: 10.1038/s12276-020-00547-x. Epub 2021 Jan 06.

In cancer cells, metabolic pathways are reprogrammed to promote cell proliferation and growth. While the rewiring of central biosynthetic pathways is being extensively studied, the dynamics of phospholipids in cancer cells are still poorly understood. In our study, we...

Cite
Lesko J, Triebl A, Stacher-Priehse E, et al. Phospholipid dynamics in ex vivo lung cancer and normal lung explants. Exp Mol Med. 2021;53(1):81-90doi: 10.1038/s12276-020-00547-x.
Lesko, J., Triebl, A., Stacher-Priehse, E., Fink-Neuböck, N., Lindenmann, J., Smolle-Jüttner, F. M., Köfeler, H. C., Hrzenjak, A., Olschewski, H., & Leithner, K. (2021). Phospholipid dynamics in ex vivo lung cancer and normal lung explants. Experimental & molecular medicine, 53(1), 81-90. https://doi.org/10.1038/s12276-020-00547-x
Lesko, Julia, et al. "Phospholipid dynamics in ex vivo lung cancer and normal lung explants." Experimental & molecular medicine vol. 53,1 (2021): 81-90. doi: https://doi.org/10.1038/s12276-020-00547-x
Lesko J, Triebl A, Stacher-Priehse E, Fink-Neuböck N, Lindenmann J, Smolle-Jüttner FM, Köfeler HC, Hrzenjak A, Olschewski H, Leithner K. Phospholipid dynamics in ex vivo lung cancer and normal lung explants. Exp Mol Med. 2021 Jan;53(1):81-90. doi: 10.1038/s12276-020-00547-x. Epub 2021 Jan 06. PMID: 33408336; PMCID: PMC8080582.
Copy Download .nbib Format: NLM
Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.

Immunologic research

Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S.
PMID: 25480741
Immunol Res. 2015 Feb;61(1):45. doi: 10.1007/s12026-014-8610-4.

No abstract available.

Cite
Artenjak A, Locatelli I, Brelih H, et al. Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res. 2015;61(1):45doi: 10.1007/s12026-014-8610-4.
Artenjak, A., Locatelli, I., Brelih, H., Simonič, D. M., Ulcova-Gallova, Z., Swadzba, J., Musial, J., Iwaniec, T., Stojanovich, L., Conti, F., Valesini, G., Avčin, T., Cohen Tervaert, J. W., Shoenfeld, Y., Blank, M., Ambrožič, A., Sodin-Semrl, S., Božič, B., & Čučnik, S. (2015). Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunologic research, 61(1), 45. https://doi.org/10.1007/s12026-014-8610-4
Artenjak, A, et al. "Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I." Immunologic research vol. 61,1 (2015): 45. doi: https://doi.org/10.1007/s12026-014-8610-4
Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S. Erratum to: Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res. 2015 Feb;61(1):45. doi: 10.1007/s12026-014-8610-4. PMID: 25480741.
Copy Download .nbib Format: NLM
High-temperature etching of SiC in SF.

Scientific reports

Osipov AA, Iankevich GA, Speshilova AB, Osipov AA, Endiiarova EV, Berezenko VI, Tyurikova IA, Tyurikov KS, Alexandrov SE.
PMID: 33203949
Sci Rep. 2020 Nov 17;10(1):19977. doi: 10.1038/s41598-020-77083-1.

In this work, we demonstrate an effective way of deep (30 µm depth), highly oriented (90° sidewall angle) structures formation with sub-nanometer surface roughness (R

Cite
Osipov AA, Iankevich GA, Speshilova AB, et al. High-temperature etching of SiC in SF. Sci Rep. 2020;10(1):19977doi: 10.1038/s41598-020-77083-1.
Osipov, A. A., Iankevich, G. A., Speshilova, A. B., Osipov, A. A., Endiiarova, E. V., Berezenko, V. I., Tyurikova, I. A., Tyurikov, K. S., & Alexandrov, S. E. (2020). High-temperature etching of SiC in SF. Scientific reports, 10(1), 19977. https://doi.org/10.1038/s41598-020-77083-1
Osipov, Artem A, et al. "High-temperature etching of SiC in SF." Scientific reports vol. 10,1 (2020): 19977. doi: https://doi.org/10.1038/s41598-020-77083-1
Osipov AA, Iankevich GA, Speshilova AB, Osipov AA, Endiiarova EV, Berezenko VI, Tyurikova IA, Tyurikov KS, Alexandrov SE. High-temperature etching of SiC in SF. Sci Rep. 2020 Nov 17;10(1):19977. doi: 10.1038/s41598-020-77083-1. PMID: 33203949; PMCID: PMC7673126.
Copy Download .nbib Format: NLM
15d-PGJ.

International journal of molecular sciences

Mikulčić M, Tabrizi-Wizsy NG, Bernhart EM, Asslaber M, Trummer C, Windischhofer W, Sattler W, Malle E, Hrzenjak A.
PMID: 34769194
Int J Mol Sci. 2021 Oct 29;22(21). doi: 10.3390/ijms222111760.

Osteosarcoma (OS) is the most common type of bone tumor, and has limited therapy options. 15-Deoxy-Δ

Cite
Mikulčić M, Tabrizi-Wizsy NG, Bernhart EM, et al. 15d-PGJ. Int J Mol Sci. 2021;22(21)doi: 10.3390/ijms222111760.
Mikulčić, M., Tabrizi-Wizsy, N. G., Bernhart, E. M., Asslaber, M., Trummer, C., Windischhofer, W., Sattler, W., Malle, E., & Hrzenjak, A. (2021). 15d-PGJ. International journal of molecular sciences, 22(21), . https://doi.org/10.3390/ijms222111760
Mikulčić, Mateja, et al. "15d-PGJ." International journal of molecular sciences vol. 22,21 (2021). doi: https://doi.org/10.3390/ijms222111760
Mikulčić M, Tabrizi-Wizsy NG, Bernhart EM, Asslaber M, Trummer C, Windischhofer W, Sattler W, Malle E, Hrzenjak A. 15d-PGJ. Int J Mol Sci. 2021 Oct 29;22(21). doi: 10.3390/ijms222111760. PMID: 34769194; PMCID: PMC8583949.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries